South & Central America Gastrointestinal Drugs Market Forecast to 2027 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South & Central America Gastrointestinal Drugs Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South & Central America Gastrointestinal Drugs Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing prevelance of gastrointestinal diosrders creates demnad for gastrointestinal drugs

5.2 Market Opportunities

5.2.1 Strategic Initiatives by Companies are likely to create ample opportunities in the coming years

5.3 Future Trends

5.3.1 Increasing research investment for novel drug development and artificial intelligence-based techniques are the key trand in coming years

5.4 Impact of Drivers and Restraints

6. South & Central America Gastrointestinal Drugs Market Regional Analysis

6.1 South & Central America Gastrointestinal Drugs Market Overview

6.2 South & Central America Gastrointestinal Drugs Market Revenue 2017-2027 (US$ Million)

6.3 South & Central America Gastrointestinal Drugs Market Forecast Analysis

7. South & Central America Gastrointestinal Drugs Market Analysis – by Drug Class

7.1 Acid Neutralizers

7.1.1 Overview
7.1.2 Acid Neutralizers: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Antidiarrheal and Laxatives

7.2.1 Overview
7.2.2 Antidiarrheal and Laxatives: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Anti-Inflammatory Drugs

7.3.1 Overview
7.3.2 Anti-Inflammatory Drugs: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Antiemetic and Antinauseants

7.4.1 Overview
7.4.2 Antiemetic and Antinauseants: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Biologics

7.5.1 Overview
7.5.2 Biologics: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Gastrointestinal Drugs Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview
8.1.2 Oral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Parenteral

8.2.1 Overview
8.2.2 Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9. South & Central America Gastrointestinal Drugs Market Analysis – by Application

9.1 Inflammatory Ulcerative Colitis

9.1.1 Overview
9.1.2 Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Crohn's Disease

9.2.1 Overview
9.2.2 Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Irritable Bowel Syndrome

9.3.1 Overview
9.3.2 Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Gastroenteritis

9.4.1 Overview
9.4.2 Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Celiac Disease

9.5.1 Overview
9.5.2 Parenteral: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10. South & Central America Gastrointestinal Drugs Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South & Central America Gastrointestinal Drugs Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 South & Central America Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 Brazil: South & Central America Gastrointestinal Drugs Market Breakdown, by Drug Class
10.1.1.1.2 Brazil: South & Central America Gastrointestinal Drugs Market Breakdown, by Route of Administration
10.1.1.1.3 Brazil: South & Central America Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.2 Argentina: South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Argentina: South & Central America Gastrointestinal Drugs Market Breakdown, by Drug Class
10.1.1.2.2 Argentina: South & Central America Gastrointestinal Drugs Market Breakdown, by Route of Administration
10.1.1.2.3 Argentina: South & Central America Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.3 Rest of South and Central America : South & Central America Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South & Central America Gastrointestinal Drugs Market Breakdown, by Drug Class
10.1.1.3.2 Rest of South and Central America : South & Central America Gastrointestinal Drugs Market Breakdown, by Route of Administration
10.1.1.3.3 Rest of South and Central America : South & Central America Gastrointestinal Drugs Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South & Central America Gastrointestinal Drugs Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Celltrion Healthcare Co.,Ltd

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GlaxoSmithKline plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Johnson and Johnson Services, Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 AstraZeneca

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Takeda Pharmaceutical Company Limited

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights